Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury
暂无分享,去创建一个
Nathan R. Qi | L. Koch | S. Britton | R. Rector | J. Ibdah | Yongzhong Wei | J. Thyfault | M. Laye | C. Burant | S. Borengasser | G. M. Uptergrove | E. Morris | Suzanne E. Ridenhour | Grace M E Uptergrove
[1] J. Sowers,et al. Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. , 2008, Journal of hepatology.
[2] F. Booth,et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[3] R. Cortright,et al. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance. , 2007, American journal of physiology. Endocrinology and metabolism.
[4] L. Koch,et al. Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance. , 2007, American journal of physiology. Endocrinology and metabolism.
[5] F. Booth,et al. Inactivity induces increases in abdominal fat. , 2007, Journal of applied physiology.
[6] Godfrey L. Smith,et al. Nitric oxide synthase type-1 modulates cardiomyocyte contractility and calcium handling: association with low intrinsic aerobic capacity , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[7] Godfrey L. Smith,et al. Nitric oxide synthase type-1 modulates cardiomyocyte contractility and calcium handling: association with low intrinsic aerobic capacity. , 2007 .
[8] R. Ross,et al. Independent associations between liver fat, visceral adipose tissue, and metabolic risk factors in men. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[9] Michaela Diamant,et al. Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease , 2006, Diabetes/metabolism research and reviews.
[10] R. Ross,et al. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. , 2006, Gastroenterology.
[11] J. Hawley,et al. It's all in the genes, so pick your parents wisely. , 2006, Journal of applied physiology.
[12] Janardan K Reddy,et al. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[13] J. Cline,et al. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. , 2005, Gastroenterology.
[14] D. Muoio,et al. Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. , 2005, American journal of physiology. Cell physiology.
[15] Ø. Ellingsen,et al. Cardiovascular Risk Factors Emerge After Artificial Selection for Low Aerobic Capacity , 2005, Science.
[16] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[17] K. Petersen,et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.
[18] A. Gasbarrini,et al. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test , 2003, American Journal of Gastroenterology.
[19] J. Arenas,et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis , 2003, Hepatology.
[20] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[21] R. Ross,et al. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. , 2003, American journal of physiology. Endocrinology and metabolism.
[22] D. Pessayre,et al. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. , 2002, Gastroenterology.
[23] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[24] Victor F. Froelicher,et al. Exercise capacity and mortality among men referred for exercise testing. , 2002, The New England journal of medicine.
[25] C. Bouchard,et al. Individual differences in response to regular physical activity. , 2001, Medicine and science in sports and exercise.
[26] J. Clore,et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.
[27] L. Tecott,et al. Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR-α) and PPAR-γ Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR-γ-Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic Mice* * This work was supported by , 2000, Endocrinology.
[28] D. Petersen,et al. Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase. , 2000, Alcoholism, clinical and experimental research.
[29] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[30] Jay D. Horton,et al. Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus* , 1999, The Journal of Biological Chemistry.
[31] R. Hammer,et al. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.
[32] J Auwerx,et al. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. , 1996, Biochimica et biophysica acta.
[33] J Auwerx,et al. Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter (*) , 1995, The Journal of Biological Chemistry.
[34] W. Kohrt,et al. Effects of gender, age, and fitness level on response of VO2max to training in 60-71 yr olds. , 1991, Journal of applied physiology.
[35] R S Paffenbarger,et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. , 1989, JAMA.
[36] C. Bouchard,et al. Aerobic performance in brothers, dizygotic and monozygotic twins. , 1986, Medicine and science in sports and exercise.
[37] C. Hoppel,et al. Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice. , 1985, The Biochemical journal.
[38] M. Connock,et al. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. , 1985, The Biochemical journal.
[39] J. McGarry,et al. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. , 1977, The Journal of clinical investigation.
[40] F. Booth,et al. Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue. , 2009, Journal of applied physiology.
[41] C. Semenkovich,et al. Fast predators or fast food, the fit still survive , 2006, Nature Medicine.
[42] M. Saier,et al. Alanine Aminotransferase , 2003 .
[43] T. Hashimoto,et al. PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .